CTX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Captor Therapeutics SA engages in the development of protein degradation drugs for cancer and autoimmune diseases. The company was founded on November 7, 2018 and is headquartered in Wroclaw, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
CTX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company